Shandong Buchang Pharmaceuticals Co., Ltd.

Shanghai Stock Exchange 603858.SS

Shandong Buchang Pharmaceuticals Co., Ltd. Receivables for the year ending December 31, 2023: USD 265.77 M

Shandong Buchang Pharmaceuticals Co., Ltd. Receivables is USD 265.77 M for the year ending December 31, 2023, a -3.74% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Shandong Buchang Pharmaceuticals Co., Ltd. Receivables for the year ending December 31, 2022 was USD 276.08 M, a -19.21% change year over year.
  • Shandong Buchang Pharmaceuticals Co., Ltd. Receivables for the year ending December 31, 2021 was USD 341.75 M, a -15.46% change year over year.
  • Shandong Buchang Pharmaceuticals Co., Ltd. Receivables for the year ending December 31, 2020 was USD 404.25 M, a 50.15% change year over year.
  • Shandong Buchang Pharmaceuticals Co., Ltd. Receivables for the year ending December 31, 2019 was USD 269.23 M, a -28.95% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
SV Wall Street
Shanghai Stock Exchange: 603858.SS

Shandong Buchang Pharmaceuticals Co., Ltd.

CEO Mr. Chao Zhao
IPO Date Nov. 18, 2016
Location China
Headquarters No. 369 Zhonghua West Road
Employees 8,311
Sector Health Care
Industries
Pharmaceuticals
Description

Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China. Shandong Buchang Pharmaceuticals Co., Ltd. was a former subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.

Similar companies

600566.SS

Hubei Jumpcan Pharmaceutical Co., Ltd.

USD 3.80

1.71%

600998.SS

Jointown Pharmaceutical Group Co., Ltd

USD 0.69

1.33%

601225.SS

Shaanxi Coal Industry Company Limited

USD 3.00

0.69%

StockViz Staff

January 31, 2025

Any question? Send us an email